By Targeting Each Patient's Unique Tumor, Precision Medicine Is Crushing Once-Untreatable Cancers. But Only a Fraction of Patients Currently Benefit. Can Medicine Close the Gap? Running story by Dave Freedman on how a combo of AI, genomics and immunology have brought us to the threshold of being able to solve just about any form of cancer; the catch is that each one will be expensive.

  Processing Request